Skip to main content Skip to section navigation Skip to footer
TCBiopharm.com

TC BioPharm Limited

  • Investors
  • Overview
  • News
    • Overview
    • Press Releases
    • Media Coverage
    • Email Alerts
  • Events & Presentations
    • Overview
    • Events
    • Presentations
  • Company Info
    • Overview
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • General Meeting
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents

Media Coverage

News

News

  • Overview
  • Press Releases
  • Media Coverage
  • Email Alerts
Jul 20, 2022

How TC BioPharm Cut 200 Manufacturing Steps and Improved Products

Jul 13, 2022

Advancing Cell Therapies – γδ T Cells and the Combination Factor

Jul 12, 2022

TC Biopharm developing gamma-delta T-cells therapies for oncology

Jul 11, 2022

Q&A With Bryan Kobel, CEO, TC BioPharm

Jul 8, 2022

CGT Live Interview – TC BioPharm Co-founder & Executive Chairman

Jul 6, 2022

Inside Gamma Delta T Cells with TC BioPharm's CEO, Bryan Kobel

Jun 22, 2022

TC BioPharm’s Co-Stimulatory CAR Therapy May Be Safer and More Economical

May 3, 2022

Q&A: Insight into the heights of biotechnology

rss_feed RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
  • Visit us on Facebook
  • Visit us on Twitter
  • Visit us on LinkedIn
©2025 TC BioPharm Limited. All Rights Reserved.
Privacy Policy Disclaimer Sitemap

This website stores cookies on your computer. These cookies, which also could include third party cookies, are used (among other purposes) to improve the website and provide more personalized services to you. To find out more about how we use cookies and how to change your settings, see our Privacy Policy.

I Accept